FESTPHASEN-FORMEN EINES PHARMAZEUTISCHEN MITTELS

European patent · EP2273994 · In force

Register entry

Publication number
EP2273994
Application number
EP09726748
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 3, 2009
Published
Jan 19, 2011
Granted
Dec 2, 2015
Protection ends at the latest
Apr 2, 2029
Next annual fee due
Apr 30, 2027
IPC classes
C07J 5/00 (2006.01)
Priority
US 42240 03.04.2008
PCT application
PCT/US2009/039567 03.04.2009
PCT publication
WO2009/124300 08.10.2009
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 1, 2026

    Change

    Published in Swissreg on 01.05.2026

  2. May 1, 2025

    Change

    Published in Swissreg on 01.05.2025

  3. May 1, 2024

    Change

    Published in Swissreg on 01.05.2024

  4. May 1, 2023

    Change

    Published in Swissreg on 01.05.2023

  5. Dec 2, 2015

    Granted

    Published in Swissreg on 02.12.2015

Parties

Holder

Neurmedix, Inc.

NeurMedix, Inc.

11601 Wilshire Blvd. No.1100, Los Angeles CA 90025, US

Inventor

WHITE, Steven, K.

San Diego CA 92129, US

IVANISEVIC, Igor

West Lafayette IN 47096, US

STEPHENS, Kyle

Farmland, IN 47340, US

ANDRES, Mark

West Lafayette IN 47096, US

WOLF, Brenton

West Lafayette IN 47906, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.